Teraimmune Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $9.7M

Teraimmune General Information

Description

Developer of cell therapeutics designed to treat autoimmune diseases and immune-related disorders. The company uses regulatory Treg cells from a donor to create Treg cells for hemophilia, multiple sclerosis, and graft-versus-host disease from stem cell transplantation, enabling the healthcare industry to develop therapeutics that help suppress the unwanted immune reactions without side effects in patients with autoimmune diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 20400 Century Boulevard
  • Suite 125
  • Germantown, MD 20874
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Corporate Office
  • 20400 Century Boulevard
  • Suite 125
  • Germantown, MD 20874
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Teraimmune Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 29-Jun-2023 $9.7M Completed Generating Revenue
4. Later Stage VC 22-Dec-2022 Completed Generating Revenue
3. Seed Round 15-Oct-2020 Completed Pre-Clinical Trials
2. Angel (individual) 09-Oct-2019 $700K $700K Completed Pre-Clinical Trials
1. Grant 01-Apr-2018 $225K Completed Startup
To view Teraimmune’s complete valuation and funding history, request access »

Teraimmune Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cell therapeutics designed to treat autoimmune diseases and immune-related disorders. The company uses regu
Drug Discovery
Germantown, MD
10 As of 2022

San Francisco, CA
 

Richmond, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Teraimmune Competitors (5)

One of Teraimmune’s 5 competitors is Sonoma Biotherapeutics, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sonoma Biotherapeutics Venture Capital-Backed San Francisco, CA
Sangamo Therapeutics Formerly VC-backed Richmond, CA
GentiBio Venture Capital-Backed Cambridge, MA
Quell Therapeutics Venture Capital-Backed London, United Kingdom
Coya Therapeutics Formerly VC-backed Houston, TX
You’re viewing 5 of 5 competitors. Get the full list »

Teraimmune Patents

Teraimmune Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024520155-A Combination composition for preventing or treating atopic dermatitis comprising functionally enhanced stem cells and regulatory t cells Inactive 01-Jun-2021
CA-3225620-A1 Combined administration composition for preventing or treating atopic dermatitis, comprising function-enhanced stem cells and regulatory t cells Pending 01-Jun-2021
US-20240277772-A1 Combined administration composition for preventing or treating atopic dermatitis, comprising function-enhanced stem cells and regulatory t cells Pending 01-Jun-2021
WO-2022255759-A1 Combined administration composition for preventing or treating atopic dermatitis, comprising function-enhanced stem cells and regulatory t cells Inactive 01-Jun-2021
AU-2022249354-A1 Method of producing regulatory t cells by culturing regulatory t cells obtained from umbilical cord blood Inactive 02-Apr-2021 C12N5/0637
To view Teraimmune’s complete patent history, request access »

Teraimmune Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Teraimmune Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alton Sports Corporation Minority
Arche Investment Corporate Venture Capital Minority
DSC Investment Venture Capital Minority
LogInvestment Venture Capital Minority
Medici Investment Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Teraimmune FAQs

  • When was Teraimmune founded?

    Teraimmune was founded in 2016.

  • Where is Teraimmune headquartered?

    Teraimmune is headquartered in Germantown, MD.

  • What is the size of Teraimmune?

    Teraimmune has 10 total employees.

  • What industry is Teraimmune in?

    Teraimmune’s primary industry is Drug Discovery.

  • Is Teraimmune a private or public company?

    Teraimmune is a Private company.

  • What is the current valuation of Teraimmune?

    The current valuation of Teraimmune is .

  • What is Teraimmune’s current revenue?

    The current revenue for Teraimmune is .

  • How much funding has Teraimmune raised over time?

    Teraimmune has raised $12.9M.

  • Who are Teraimmune’s investors?

    Alton Sports, Arche Investment, DSC Investment, LogInvestment, and Medici Investment are 5 of 9 investors who have invested in Teraimmune.

  • Who are Teraimmune’s competitors?

    Sonoma Biotherapeutics, Sangamo Therapeutics, GentiBio, Quell Therapeutics, and Coya Therapeutics are competitors of Teraimmune.

  • When was Teraimmune acquired?

    Teraimmune was acquired on 29-Jun-2023.

  • Who acquired Teraimmune?

    Teraimmune was acquired by Baudax Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process